Patents matching “BOARD OF REGENTS”

US 9789205

Compositions and methods for gene therapy

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 17, 2017 · Expires Oct 12, 2037

US 9789131

Compounds and methods for treating neurological and cardiovascular conditions

The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

US 9790233

Compositions and methods of modulating 15-PGDH activity

The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

US 9782464

Methods and compositions for inhibiting diseases of the central nervous system

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 10, 2017 · Expires Oct 5, 2037

US 9783550

Highly potent inhibitors of porcupine

The Board of Regents of the University of Texas System · Granted Oct 10, 2017 · Expires Oct 5, 2037

US 9779497

Measuring glomerular number from kidney MRI images

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 3, 2017 · Expires Sep 28, 2037

US 9770504

Generating peptoid vaccines

The Board of Regents of the University of Texas System · Granted Sep 26, 2017 · Expires Sep 21, 2037

US 9770500

S-nitrosylation of glucosylating toxins and uses therefor

The Board of Regents of the University of Texas System · Granted Sep 26, 2017 · Expires Sep 21, 2037

US 9765099

STAT6 inhibitors

The Board of Regents of the University of Texas System · Granted Sep 19, 2017 · Expires Sep 14, 2037

US 9765027

Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparation

Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 19, 2017 · Expires Sep 14, 2037

US 9757472

Proteas stabilized antibacterial peptides for S. aureus

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 12, 2017 · Expires Sep 7, 2037

US 9757379

Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)

The Board of Regents of the University of Texas System · Granted Sep 12, 2017 · Expires Sep 7, 2037

US 9751970

Block copolymer and micelle compositions and methods of use thereof

The Board of Regents of the University of Texas System · Granted Sep 5, 2017 · Expires Aug 31, 2037

US 9750849

Oxygen generating biomaterial

The Board of Regents of the University of Texas System · Granted Sep 5, 2017 · Expires Aug 31, 2037

US 9744235

Treatment of cardiovascular disorders with targeted nanoparticles

The Board of Regents of the University of Oklahoma · Granted Aug 29, 2017 · Expires Aug 24, 2037

US 9744142

Formulations of volatile anesthetics and methods of use for reducing inflammation

The Board of Regents of the University of Texas System · Granted Aug 29, 2017 · Expires Aug 24, 2037

US 9737512

Methods and compositions for treating chronic pain

The Board of Regents of the University of Texas System · Granted Aug 22, 2017 · Expires Aug 17, 2037

US 9737527

Biopolymer drug loading method

SOUTH DAKOTA BOARD OF REGENTS · Granted Aug 22, 2017 · Expires Aug 17, 2037

US 9731023

Somatostatin receptor-based cancer therapy

The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9730954

miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9732114

Compounds having anti-adhesive effects on cancer cells

The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9730894

Stabilized HME composition with small drug particles

The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9725460

Oridonin analogs, compositions, and methods related thereto

The Board of Regents of the University of Texas System · Granted Aug 8, 2017 · Expires Aug 3, 2037

US 9725520

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

The Board of Regents of the University of Texas System · Granted Aug 8, 2017 · Expires Aug 3, 2037